Bi-monthly hepatic arterial infusion chemotherapy as a novel strategy for advanced hepatocellular carcinoma in decompensated cirrhotic patients

Bi-monthly hepatic arterial infusion chemotherapy as a novel strategy for advanced hepatocellular carcinoma in decompensated cirrhotic patients

Background and Aims We previously reported the comparable efficacy of bi-monthly hepatic arterial infusion chemotherapy (B-HAIC) to that of sorafenib chemotherapy for the treatment of advanced hepatocellular carcinoma (aHCC) in patients with compensated cirrhosis. In this study, we demonstrate the e...

Full description

Bibliographic Details
Main Authors: Kei Moriya, Tadashi Namisaki, Shinya Sato, Masanori Furukawa, Akitoshi Douhara, Hideto Kawaratani, Kosuke Kaji, Naotaka Shimozato, Yasuhiko Sawada, Soichiro Saikawa, Hiroaki Takaya, Koh Kitagawa, Takemi Akahane, Akira Mitoro, Junichi Yamao, Hitoshi Yoshiji
Format: Article
Language:English
Published: Korean Association for the Study of the Liver 2019-12-01
Series:Clinical and Molecular Hepatology
Subjects:
carcinoma, hepatocellular
liver cirrhosis
cisplatin
drug therapy
decompensated cirrhosis
Online Access:http://e-cmh.org/upload/pdf/cmh-2019-0037.pdf

Internet

http://e-cmh.org/upload/pdf/cmh-2019-0037.pdf

Similar Items